Levels of commitment: exploring complementary therapy use by women with breast cancer
- PMID: 16813510
- DOI: 10.1089/acm.2006.12.459
Levels of commitment: exploring complementary therapy use by women with breast cancer
Abstract
Objectives: Previous research on complementary therapy use in populations of patients with breast cancer has failed to differentiate among the different types of therapies and utilization patterns, resulting in wide discrepancies in prevalence rates. The purpose of this study was to develop more refined and rigorous estimates of the prevalence of complementary therapy use in women with breast cancer and their level of commitment to complementary therapy. DESIGN AND SAMPLE/SETTING: Using a cross-sectional, retrospective survey design, a random sample of 334 women with breast cancer was drawn from a Canadian provincial cancer registry. Using an intensive therapy inventory, women were asked to indicate the therapies and practices they had used since cancer diagnosis, frequency of use, amount of effort associated with using each therapy, and financial cost of therapy use.
Results: A substantial proportion of women with breast cancer were found to be using complementary therapies, with between 19.5% (most conservative estimate) and 79.9% (liberal estimate) of the women reporting the use of at least one complementary therapy following diagnosis. While the majority of therapies were used on a daily basis, a minimal amount of effort and finances was expended on complementary therapy use. Using two-way cluster analysis, two homogenous groups of complementary therapy users were identified based on level of commitment to complementary therapy use. Women with a low commitment to complementary therapy use comprised 73.9% of the sample and were more likely to be older and report less education than women with a moderate-to-high commitment to complementary therapy use.
Conclusions: The use of complementary therapies by women with breast cancer warrants more precise measurement to accurately capture the types of complementary therapies used and the level of commitment to complementary therapy use. The findings of this study point to the value of the concept of commitment in identifying individuals willing to commit substantial time, energy and financial resources to complementary therapy use.
Similar articles
-
Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.Nurs Res. 2010 Jan-Feb;59(1):58-66. doi: 10.1097/NNR.0b013e3181c3bd26. Nurs Res. 2010. PMID: 20010046
-
Use of complementary and alternative therapies in community-dwelling older adults.J Altern Complement Med. 2007 Nov;13(9):997-1006. doi: 10.1089/acm.2007.0527. J Altern Complement Med. 2007. PMID: 18047447
-
Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.Oncol Nurs Forum. 2003 Sep-Oct;30(5):811-21. doi: 10.1188/03.ONF.811-821. Oncol Nurs Forum. 2003. PMID: 12949594
-
The use of complementary and alternative medicine by pregnant women: a literature review.Midwifery. 2011 Dec;27(6):817-24. doi: 10.1016/j.midw.2010.08.007. Epub 2011 Jan 17. Midwifery. 2011. PMID: 21247674 Review.
-
Complementary and alternative medicine use among women with breast cancer.J Clin Oncol. 2002 Sep 15;20(18 Suppl):34S-8S. J Clin Oncol. 2002. PMID: 12235222 Review.
Cited by
-
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?Eur J Clin Pharmacol. 2012 May;68(5):811-9. doi: 10.1007/s00228-011-1181-6. Epub 2011 Dec 14. Eur J Clin Pharmacol. 2012. PMID: 22166933
-
Mapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive "exceptional" experiences.BMC Complement Altern Med. 2008 Aug 8;8:48. doi: 10.1186/1472-6882-8-48. BMC Complement Altern Med. 2008. PMID: 18691393 Free PMC article.
-
Implicit Reasons for Disclosure of the Use of Complementary Health Approaches (CHA): a Consumer Commitment Perspective.Ann Behav Med. 2017 Oct;51(5):764-774. doi: 10.1007/s12160-017-9900-6. Ann Behav Med. 2017. PMID: 28432577 Free PMC article.
-
Canadian integrative oncology research priorities: results of a consensus-building process.Curr Oncol. 2013 Aug;20(4):e289-99. doi: 10.3747/co.20.1378. Curr Oncol. 2013. PMID: 23904767 Free PMC article.
-
Reasons for continuing use of Complementary and Alternative Medicine (CAM) in students: a consumer commitment model.BMC Complement Altern Med. 2016 Feb 24;16:75. doi: 10.1186/s12906-016-1059-3. BMC Complement Altern Med. 2016. PMID: 26911133 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical